Qlosi™

Presbyopia

ApprovedActive

Key Facts

Indication

Presbyopia

Phase

Approved

Status

Active

Company

Orasis delivers a prescription eye‑drop solution for presbyopia, aiming to reshape vision possibilities with a non‑invasive drug.

Drug	Company	Phase	Status
Presbyopia Treatment	Viatris (2)	NDA Submitted	Active
Presbyopia-Correcting ICL	STAAR Surgical	Research & Development	Active R&D
LB-01	Lento Bio	Discovery/IND-Enabling	Active
LB-02	Lento Bio	Discovery	Active
Presbyopia-Correcting Contact Lenses	Clerio Vision	Development	Active
Intra-corneal Implant	MAG Optics	Pre-clinical	Active
NVK029	Vyluma	Phase 2	Active
ArtiPlus	Ophtec	Clinical Trials	Active
BRIMOCHOL™ PF	Tenpoint Therapeutics	NDA Submitted	Active
TSH‑001	TSH Biopharm	Phase 1/2	Active
DE-128A	Santen Pharmaceutical	Phase 2	Active
YP-10	Viatris	NDA Filed	Under FDA Review (PDUFA date set)